Precursor Ventures

Precursor Ventures is a pre‑seed and seed‑stage venture firm that invests primarily in North America, with a global exception for fintech. It is sector‑agnostic, allocating roughly half of its capital to B2B and half to B2C software and hardware businesses. The firm explicitly avoids biotech and life‑science companies because it lacks scientific expertise, and it does not enter at Series A or in rounds larger than $5 M. Check sizes are typically up to $500 K per company, with the ability to lead rounds of $1 M or less. Precursor believes that value creation is driven by backing “people over product” – the strongest founders are funded as the first institutional check, allowing the firm to shape the zero‑to‑one journey and provide follow‑on capital. By maintaining reserves for later rounds and staying away from capital‑intensive, non‑technology‑centric businesses, Precursor aims to capture outsized upside from early‑stage companies that can scale to large revenues once the founder’s vision is validated.

Precursor’s evaluation framework is fundamentally team‑first, followed by market and then product. Internally the firm weights roughly 70 % founder quality and 30 % market attractiveness, requiring the market to be at least “not hated.” Traction is not a prerequisite; the firm often invests in the “no‑data” quadrant where both business and founder information are scarce, giving it a competitive edge. Decision‑makers look for durable, non‑obvious advantages in business model or market segmentation, and they apply a mental scorecard asking if the company could reach $100 M ARR in seven years with healthy margins. Deal‑breakers include conflicts with existing portfolio companies, entry at Series A, and investments in biotech or capital‑intensive businesses without a clear technology angle. Typical deals are pre‑seed or seed rounds ≤$5 M, with initial checks of $250‑$500 K, and the firm keeps reserves for follow‑on support.

• ClutchLead
  Creator/SMB marketplace backing an early team at pre‑seed; aligns with the firm’s focus on people over product and consumer‑focused bets.
• Empromptu AILead
  Enterprise AI infrastructure at the earliest stage; matches the generalist thesis of backing strong technical founders.
• Xella HealthLead
  Women’s precision‑health platform combining diagnostics and AI; fits the firm’s early digital‑health bets.
• PlayMaker SoftwareLead
  Vertical SaaS for sponsorship operations; classic early B2B product in a niche market, aligning with a software focus.
• Grw AILead
  AI‑driven B2B SaaS for sales coaching; early‑stage enterprise software with strong founder‑market fit.
• ApprovedLead
  Fintech infrastructure for mortgages from repeat operators; co‑led first institutional check consistent with the firm’s “first round” approach.
• Carrot Fertility
  Digital‑health benefits leader; notable early support of a category‑defining company.
• The Athletic
  Consumer subscription media that later achieved a high‑profile exit; early investor in a landmark media startup.
• Pair Eyewear
  Consumer/DTC eyewear brand with product innovation and strong brand; Precursor participated as part of an early syndicate.
• Incredible Health
  Healthcare labor marketplace that scaled into later rounds; early participation fits the firm’s health‑tech interest.

• 
  Uncork Capital

  Carrot Fertility